Skip to main content

Table 3 Roles of TAM-derived cytokines in gynecological and breast cancers

From: Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers

Cytokines

Tumor type

Interacting molecules

Function

References

IL-6

Cervical cancer

IL-6/JAK/STAT3

HPV E6 oncoprotein participates in the phosphorylation activation of the STAT pathway by IL-6 and promotes cancer cell proliferation

[84]

 

ER-positive breast cancer

 

The IL6/STAT3 pathway independent of ER pathway promotes the proliferation of cancer cells

[86]

IL-1

Breast cancer

sCD44

A novel positive feedback loop between IL1β and CD44 promotes TNBC malignant progression

[75]

IGF-1

Breast cancer

Akt

Serum IGF-1 concentrations and IGF-I/IGFBP3 ratio correlated with Akt phosphorylation which promote breast cancer progression and poor disease outcome

[77]

CXCL8/IL-8

Endometrial carcinoma

HOXB13

Down-regulation of ERα expression in endometrial carcinoma, leading to tumor invasion and poor prognosis

[88]

 

ER-positive breast cancer

HOXB13, mTOR

Up-regulation of HOXB13 can promote cell proliferation and metastasis in vitro and in vivo by directly inhibiting ERα, while ERα can be inhibited by decreasing the expression of mTOR

[89]

 

Epithelial ovarian cancer

Estrogen, IL-6

Estrogen, IL-6 and CXCL8 interact to regulate epithelial ovarian cancer growth through a cascade of amplification effects of ERα pathway

[91, 92]

VEGF-C/D

Endometrial cancer and cervical cancer

VEGFR-3

VEGF-C, VEGF-D and receptor VEGFR-3 are correlated with different stages of tumor progression

[95, 96]

EGF

Ovarian cancer

VEGF

EGFR activation and up-regulation of VEGF/VEGFR signaling pathway in surrounding tumor cells supported tumor cell proliferation and migration. EGF up-regulated αMβ2 integrin and ICAM-1 and promoted the adhesion of tumor cells to TAMs

[99]

MMP-9

ER-positive breast cancer

ER

TAMs secretion of MMP-9 is associated with reduced overall survival via ER

[104]

MMP-7

Ovarian cancer

p38

MMP-7 promoted macrophage infiltration to further form tumor microenvironment

[105]

uPA

Breast ductal carcinoma in situ

uPAR

uPA reshaped the extracellular matrix by degrading the components involved, which in turn led to the removal of tumor cells from the primary site

[110]

TNF-α

Breast cancer

Estrogen

TNF-α involved in EMT and metastasis of breast cancer cells

[76]

IL-10

Cervical cancer

HPV E2

T cell

HPV E2 protein could bind to IL-10 gene promoter, triggering the increase in IL-10. Increased IL-10 inhibited T cell immunity

[118, 119]

 

Breast cancer

CD8+ T cell

Macrophage-derived IL-10 overexpression leads to tumor development in response to CD8+ T cell-dependent chemotherapy

[121, 122]

TGF-β1

Cervical cancer

HPV E6/E7

As tumors develop, TGF-β induces EMT

[118]

 

High-grade serous ovarian cancer

Unknown

High levels of TGF-β1 secretion promote peritoneal metastasis of cancer cells

[112]

GDF15

Cervical cancer

PI3K/AKT and MAPK/ERK

The PI3K/AKT and MAPK/ERK signaling pathways are phosphorylated by ErbB2 to promote tumor progression

[113]